Trial Outcomes & Findings for The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria (NCT NCT03394391)
NCT ID: NCT03394391
Last Updated: 2019-11-15
Results Overview
ART adherence is assessed by different well-validated methods. In this study, ART adherence will be measured, primarily, using the self-report visual analog scale. The scale is well-validated, self-report of the level of ART adherence with a range from 0 to 100%. While higher values indicate better levels of adherence, patients with adherence levels of 95% and above are regarded as ART-adherent while those with values less than 95% are not adherent to ART medications. Viral load is the number of copies of viral RNA detected in participants' blood. Participants with viral load \</=20 copies per ml are regarded to have optimal viral suppression indicative of optimal adherence to medications.
COMPLETED
NA
212 participants
20week [End of study]
2019-11-15
Participant Flow
Participants were recruited while attending routine clinic visits across five (5) high patient-density ART sites in 2 States in South West, Nigeria over a 13 week period.
There was no significant event.
Participant milestones
| Measure |
Intervention Group
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
|---|---|---|
|
Overall Study
STARTED
|
106
|
106
|
|
Overall Study
COMPLETED
|
105
|
104
|
|
Overall Study
NOT COMPLETED
|
1
|
2
|
Reasons for withdrawal
| Measure |
Intervention Group
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
1
|
2
|
Baseline Characteristics
The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria
Baseline characteristics by cohort
| Measure |
Intervention Group
n=106 Participants
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
n=106 Participants
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Total
n=212 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
16.56 years
STANDARD_DEVIATION 1.41 • n=99 Participants
|
16.66 years
STANDARD_DEVIATION 1.36 • n=107 Participants
|
16.61 years
STANDARD_DEVIATION 1.38 • n=206 Participants
|
|
Sex: Female, Male
Female
|
51 Participants
n=99 Participants
|
53 Participants
n=107 Participants
|
104 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
55 Participants
n=99 Participants
|
53 Participants
n=107 Participants
|
108 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Yoruba
|
67 Participants
n=99 Participants
|
67 Participants
n=107 Participants
|
134 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Hausa
|
3 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
5 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Igbo
|
24 Participants
n=99 Participants
|
26 Participants
n=107 Participants
|
50 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Others
|
12 Participants
n=99 Participants
|
11 Participants
n=107 Participants
|
23 Participants
n=206 Participants
|
|
Region of Enrollment
Nigeria
|
106 participants
n=99 Participants
|
106 participants
n=107 Participants
|
212 participants
n=206 Participants
|
|
Baseline ART Adherence (VAS)
VAS adherence (Self report of >/=95% adherence)
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Baseline ART Adherence (VAS)
Viral Load </= 20
|
54 Participants
n=99 Participants
|
49 Participants
n=107 Participants
|
103 Participants
n=206 Participants
|
PRIMARY outcome
Timeframe: 20week [End of study]ART adherence is assessed by different well-validated methods. In this study, ART adherence will be measured, primarily, using the self-report visual analog scale. The scale is well-validated, self-report of the level of ART adherence with a range from 0 to 100%. While higher values indicate better levels of adherence, patients with adherence levels of 95% and above are regarded as ART-adherent while those with values less than 95% are not adherent to ART medications. Viral load is the number of copies of viral RNA detected in participants' blood. Participants with viral load \</=20 copies per ml are regarded to have optimal viral suppression indicative of optimal adherence to medications.
Outcome measures
| Measure |
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
|---|---|---|
|
ART Adherence at 20 Weeks as Determined by VAS, Viral Load
Adherence by VAS
|
57 Participants
|
47 Participants
|
|
ART Adherence at 20 Weeks as Determined by VAS, Viral Load
Viral Load </= 20 copies
|
63 Participants
|
46 Participants
|
PRIMARY outcome
Timeframe: 20week [End of study]AIDS Clinical Trials Group Scale scores range from 0 to 1. The higher scores reflect better ART adherence Pill count scores also range from 0 to 1 and the higher scores also reflect better adherence. Visual analog scale \[VAS\] adherence ranges between 0 and 100%. Higher scores reflect better ART adherence
Outcome measures
| Measure |
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
|---|---|---|
|
ART Adherence at 20 Weeks as Determined by Pill Counts, ACTG Adherence Questionnaire, and VAS Scores
AIDS Clinical Trials Group Scale score
|
0.92 measurement vlaues and score on a scale
Standard Deviation 0.15
|
0.90 measurement vlaues and score on a scale
Standard Deviation 0.17
|
|
ART Adherence at 20 Weeks as Determined by Pill Counts, ACTG Adherence Questionnaire, and VAS Scores
Pill count score score
|
0.68 measurement vlaues and score on a scale
Standard Deviation 0.24
|
0.65 measurement vlaues and score on a scale
Standard Deviation 0.28
|
|
ART Adherence at 20 Weeks as Determined by Pill Counts, ACTG Adherence Questionnaire, and VAS Scores
VAS score, continuous
|
89.04 measurement vlaues and score on a scale
Standard Deviation 11.90
|
86.99 measurement vlaues and score on a scale
Standard Deviation 13.50
|
PRIMARY outcome
Timeframe: 20 week [End of study]Viral load count is measured in copies per ml. The minimum value is 0. There is no maximum value. The higher values reflect poor adherence
Outcome measures
| Measure |
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
|---|---|---|
|
ART Adherence at 20 Weeks as Determined by Viral Load Count
|
11678 copies/mL
Standard Deviation 51003.77
|
42676.71 copies/mL
Standard Deviation 147790.6
|
PRIMARY outcome
Timeframe: 20week [End of study]log of viral load count is log 10 transformation of the viral load values
Outcome measures
| Measure |
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
|---|---|---|
|
ART Adherence at 20 Weeks as Determined by Log of Viral Load Count
|
1.97 log10 copies/mL
Standard Deviation 1.30
|
2.63 log10 copies/mL
Standard Deviation 1.55
|
SECONDARY outcome
Timeframe: End of Study (20weeks)Patient satisfaction will be assessed using a 22-item adaptation of the SERVQUAL tool. It is a multi-dimensional service quality assessment tool that uses a 5-point likert scale scored from 1 to 5 points to assess 5 domains of client satisfaction. The domains are tangibility (4 items; scores from 4 to 20), reliability (5 items; scores from 5 to 25), responsiveness (4 items; scores from 4 to 20), assurance (4 items; scores from 4 to 20), and empathy (5 items; scores from 5 to 25). Patient satisfaction is measured by the total score which will range between 22 and 110. Higher scores indicate better client satisfaction.
Outcome measures
| Measure |
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
|---|---|---|
|
Patient Satisfaction Score at 20 Weeks
|
88.94 score on a scale
Standard Deviation 9.26
|
91.76 score on a scale
Standard Deviation 8.72
|
SECONDARY outcome
Timeframe: End of study (20weeks)The General Health Questionnaire 12 (GHQ12) will be used to assess the mental health status of all the participants. It is a well-validated and widely used instrument for screening for mental health distress. It is a 12-item questionnaire that is based on a 4-point likert scale scored from 0 to 3 points. The scores will range between 0 and 36. A score of 12 or more is suggestive of mental distress while scores less than 12 suggest that mental distress is absent.
Outcome measures
| Measure |
Intervention Group
n=105 Participants
Daily ART-adherence SMS reminder
Daily ART-adherence SMS reminder: Interactive and tailored SMS reminders that are acceptable to the participants to remind them to take their medications and to make clinic attendance.
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
Control Group
n=104 Participants
Standard adherence counselling/Patient experience group chat
Standard Adherence Counselling/Patient experience group chat: All the participants will receive the standard adherence counselling by trained counsellors at each visit.
All participants will also be enlisted in a group chat on social media where they will discuss their experiences with the quality of HIV services rendered at their respective clinics. A specialist who will have very minimal involvement will give weekly feedback and counsel on how best to resolve prominent challenges.
|
|---|---|---|
|
Number of Participants With Mental Distress Determined by General Health Questionnaire 12 at 20 Weeks
|
2 Participants
|
11 Participants
|
Adverse Events
Intervention Group
Control Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place